OptimizeRx Corp Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: OptimizeRx Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
OptimizeRx Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.56M, a 141% decline year-over-year.
OptimizeRx Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$28.3M, a 73.2% decline year-over-year.
OptimizeRx Corp annual Operating Income (Loss) for 2023 was -$26.4M, a 115% decline from 2022.
OptimizeRx Corp annual Operating Income (Loss) for 2022 was -$12.3M, a 3504% decline from 2021.
OptimizeRx Corp annual Operating Income (Loss) for 2021 was $361K.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Annual (USD)

Operating Income (Loss), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	-$26.4M	-$14.1M	-115%	Jan 1, 2023	Dec 31, 2023	10-K	2024-04-15
2022	-$12.3M	-$12.7M	-3504%	Jan 1, 2022	Dec 31, 2022	10-K	2024-04-15
2021	$361K	+$2.5M		Jan 1, 2021	Dec 31, 2021	10-K	2023-03-10
2020	-$2.14M	+$1.56M	+42.2%	Jan 1, 2020	Dec 31, 2020	10-K/A	2023-03-10
2019	-$3.69M	-$3.87M	-2150%	Jan 1, 2019	Dec 31, 2019	10-K	2021-03-08
2018	$180K	+$2.31M		Jan 1, 2018	Dec 31, 2018	10-K	2020-03-26
2017	-$2.13M	-$548K	-34.7%	Jan 1, 2017	Dec 31, 2017	10-K	2019-03-12
2016	-$1.58M	-$984K	-165%	Jan 1, 2016	Dec 31, 2016	10-K	2018-03-08
2015	-$597K	+$429K	+41.8%	Jan 1, 2015	Dec 31, 2015	10-K	2017-03-08
2014	-$1.03M	-$759K	-284%	Jan 1, 2014	Dec 31, 2014	10-K	2016-03-15
2013	-$268K	+$187K	+41.2%	Jan 1, 2013	Dec 31, 2013	10-K/A	2015-09-16
2012	-$455K	+$999K	+68.7%	Jan 1, 2012	Dec 31, 2012	10-K	2014-03-31
2011	-$1.45M	+$392K	+21.2%	Jan 1, 2011	Dec 31, 2011	10-K	2013-03-12
2010	-$1.85M			Jan 1, 2010	Dec 31, 2010	10-K	2012-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.